These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35243556)

  • 1. Three new inhibitors of class A β-lactamases evaluated by molecular docking and dynamics simulations methods: relebactam, enmetazobactam, and QPX7728.
    Saral Sariyer A
    J Mol Model; 2022 Mar; 28(4):76. PubMed ID: 35243556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from
    Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM
    ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985
    [No Abstract]   [Full Text] [Related]  

  • 3. The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant
    Lomovskaya O; Rubio-Aparicio D; Tsivkovski R; Loutit J; Dudley M
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216821. PubMed ID: 34902261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae.
    Tselepis L; Langley GW; Aboklaish AF; Widlake E; Jackson DE; Walsh TR; Schofield CJ; Brem J; Tyrrell JM
    Int J Antimicrob Agents; 2020 Jul; 56(1):105925. PubMed ID: 32084512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases.
    Tsivkovski R; Totrov M; Lomovskaya O
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32152086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in
    Lomovskaya O; Nelson K; Rubio-Aparicio D; Tsivkovski R; Sun D; Dudley MN
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases.
    Lomovskaya O; Tsivkovski R; Nelson K; Rubio-Aparicio D; Sun D; Totrov M; Dudley MN
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition.
    Hinchliffe P; Tooke CL; Bethel CR; Wang B; Arthur C; Heesom KJ; Shapiro S; Schlatzer DM; Papp-Wallace KM; Bonomo RA; Spencer J
    mBio; 2022 Jun; 13(3):e0179321. PubMed ID: 35612361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based virtual screening, molecular docking, and molecular dynamics simulation approaches for identification of new potential inhibitors of class a β-lactamase enzymes.
    Khademi Dehkordi M; Hoveida L; Fani N
    J Biomol Struct Dyn; 2024 Jul; 42(11):5631-5641. PubMed ID: 37534493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigmoid
    Knechtle P; Shapiro S; Morrissey I; De Piano C; Belley A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0092621. PubMed ID: 34097479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
    Isler B; Harris P; Stewart AG; Paterson DL
    J Antimicrob Chemother; 2021 Feb; 76(3):550-560. PubMed ID: 33332545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
    Karlowsky JA; Lob SH; Kazmierczak KM; Hawser SP; Magnet S; Young K; Motyl MR; Sahm DF
    J Antimicrob Chemother; 2018 Jul; 73(7):1872-1879. PubMed ID: 29659861
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lomovskaya O; Rubio-Aparicio D; Nelson K; Sun D; Tsivkovski R; Castanheira M; Lindley J; Loutit J; Dudley M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing
    Shapiro S
    Antimicrob Agents Chemother; 2022 May; 66(5):e0029822. PubMed ID: 35471043
    [No Abstract]   [Full Text] [Related]  

  • 16. Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.
    Papp-Wallace KM; Barnes MD; Alsop J; Taracila MA; Bethel CR; Becka SA; van Duin D; Kreiswirth BN; Kaye KS; Bonomo RA
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam.
    Belley A; Morrissey I; Hawser S; Kothari N; Knechtle P
    J Glob Antimicrob Resist; 2021 Jun; 25():93-101. PubMed ID: 33746112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
    Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics.
    Lomovskaya O; Tsivkovski R; Sun D; Reddy R; Totrov M; Hecker S; Griffith D; Loutit J; Dudley M
    Front Microbiol; 2021; 12():697180. PubMed ID: 34290688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa.
    López-Pérez M; Haro-Moreno JM; Molina-Pardines C; Ventero MP; Rodríguez JC
    mSphere; 2021 Dec; 6(6):e0083621. PubMed ID: 34817240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.